Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 6,554 | 13,384 | 7,078 | 3,329 | 3,500 |
| Gross Profit | 6,554 | 13,384 | 7,078 | 3,329 | 3,500 |
| Operating Expenses | 16,253 | 14,030 | 15,111 | 14,927 | 12,451 |
| Operating Income | -9,699 | -646 | -8,033 | -11,598 | -8,951 |
| Interest Expense | 0 | 154 | 330 | 348 | 363 |
| Other Income | 641 | 586 | 878 | 534 | 448 |
| Pre-tax Income | -9,058 | -214 | -7,485 | -11,412 | -8,866 |
| Income Tax | -203 | -39 | -1 | -36 | 5 |
| Net Income Continuous | -8,855 | -175 | -7,484 | -11,376 | -8,871 |
| Net Income | $-8,855 | $-175 | $-7,484 | $-11,376 | $-8,871 |
| EPS Basic Total Ops | -0.25 | 0.00 | -0.22 | -0.42 | -0.33 |
| EPS Basic Continuous Ops | -0.25 | -0.01 | -0.23 | -0.43 | -0.34 |
| EPS Diluted Total Ops | -0.25 | 0.00 | -0.22 | -0.42 | -0.33 |
| EPS Diluted Continuous Ops | -0.25 | -0.01 | -0.23 | -0.43 | -0.34 |
| EBITDA(a) | $-9,528 | $-400 | $-7,792 | $-11,315 | $-8,714 |